{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T20:36:32Z","timestamp":1783110992483,"version":"3.54.6"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T00:00:00Z","timestamp":1740182400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"This work was supported by Medical Scientific Research Foundation of Southwest Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr. Diabetes"],"DOI":"10.1038\/s41387-025-00355-0","type":"journal-article","created":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T06:13:11Z","timestamp":1740204791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["ZHX2 inhibits diabetes-induced liver injury and ferroptosis by epigenetic silence of YTHDF2"],"prefix":"10.1038","volume":"15","author":[{"given":"Wei","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5299-6238","authenticated-orcid":false,"given":"Linghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,22]]},"reference":[{"key":"355_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100275","volume":"8","author":"S Demir","year":"2021","unstructured":"Demir S, Nawroth PP, Herzig S, Ekim Ustunel B. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh). 2021;8:e2100275.","journal-title":"Adv Sci (Weinh)"},{"key":"355_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113888","volume":"176","author":"V Kumar","year":"2021","unstructured":"Kumar V, Xin X, Ma J, Tan C, Osna N, Mahato RI. Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis. Adv Drug Deliv Rev. 2021;176:113888.","journal-title":"Adv Drug Deliv Rev"},{"key":"355_CR3","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/joim.13531","volume":"292","author":"R Paternostro","year":"2022","unstructured":"Paternostro R, Trauner M. Current treatment of non-alcoholic fatty liver disease. J Intern Med. 2022;292:190\u2013204.","journal-title":"J Intern Med"},{"key":"355_CR4","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","volume":"18","author":"G Targher","year":"2021","unstructured":"Targher G, Corey KE, Byrne CD, Roden M. The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments. Nat Rev Gastroenterol Hepatol. 2021;18:599\u2013612.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"355_CR5","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1007\/s00125-016-3952-1","volume":"59","author":"K Cusi","year":"2016","unstructured":"Cusi K. Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions. Diabetologia. 2016;59:1112\u201320.","journal-title":"Diabetologia"},{"key":"355_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","volume":"10","author":"N Stefan","year":"2022","unstructured":"Stefan N, Cusi K. A global view of the interplay between non-alcoholic fatty liver disease and diabetes. Lancet Diabetes Endocrinol. 2022;10:284\u201396.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"355_CR7","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17:2054\u201381.","journal-title":"Autophagy"},{"key":"355_CR8","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2346543","volume":"56","author":"Q Wu","year":"2024","unstructured":"Wu Q, Huang F. Targeting ferroptosis as a prospective therapeutic approach for diabetic nephropathy. Ann Med. 2024;56:2346543.","journal-title":"Ann Med"},{"key":"355_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05191-x","volume":"22","author":"Y Chen","year":"2024","unstructured":"Chen Y, Zhao W, Hu A, Lin S, Chen P, Yang B, et al. Type 2 diabetic mellitus related osteoporosis: focusing on ferroptosis. J Transl Med. 2024;22:409.","journal-title":"J Transl Med"},{"key":"355_CR10","doi-asserted-by":"publisher","first-page":"8253","DOI":"10.1007\/s12035-024-04097-5","volume":"61","author":"X Cheng","year":"2024","unstructured":"Cheng X, Tan Y, Li H, Zhang Z, Hui S, Zhang Z. et al. Mechanistic insights and potential therapeutic implications of NRF2 in diabetic encephalopathy. Mol Neurobiol. 2024;61:8253\u201378.","journal-title":"Mol Neurobiol"},{"key":"355_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.7150\/ijms.88476","volume":"21","author":"Z Song","year":"2024","unstructured":"Song Z, Wang J, Zhang L. Ferroptosis: a new mechanism in diabetic cardiomyopathy. Int J Med Sci. 2024;21:612\u201322.","journal-title":"Int J Med Sci"},{"key":"355_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.102142","volume":"93","author":"SY Li","year":"2024","unstructured":"Li SY, Zhao N, Wei D, Pu N, Hao XN, Huang JM, et al. Ferroptosis in the ageing retina: A malevolent fire of diabetic retinopathy. Ageing Res Rev. 2024;93:102142.","journal-title":"Ageing Res Rev"},{"key":"355_CR13","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1111\/liv.15163","volume":"42","author":"G Feng","year":"2022","unstructured":"Feng G, Byrne CD, Targher G, Wang F, Zheng MH. Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link? Liver Int. 2022;42:1496\u2013502.","journal-title":"Liver Int"},{"key":"355_CR14","doi-asserted-by":"publisher","first-page":"9309","DOI":"10.3390\/ijms23169309","volume":"23","author":"A Stancic","year":"2022","unstructured":"Stancic A, Velickovic K, Markelic M, Grigorov I, Saksida T, Savic N, et al. Involvement of ferroptosis in diabetes-induced liver pathology. Int J Mol Sci.2022;23:9309.","journal-title":"Int J Mol Sci."},{"key":"355_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"Guo T, Yan W, Cui X, Liu N, Wei X, Sun Y, et al. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol Med. 2023;29:132.","journal-title":"Mol Med"},{"key":"355_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","volume":"22","author":"M Yang","year":"2023","unstructured":"Yang M, Xia L, Song J, Hu H, Zang N, Yang J, et al. Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation. Lipids Health Dis. 2023;22:202.","journal-title":"Lipids Health Dis"},{"key":"355_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176341","volume":"966","author":"T Zhang","year":"2024","unstructured":"Zhang T, Wang MY, Wang GD, Lv QY, Huang YQ, Zhang P, et al. Metformin improves nonalcoholic fatty liver disease in db\/db mice by inhibiting ferroptosis. Eur J Pharmacol. 2024;966:176341.","journal-title":"Eur J Pharmacol"},{"key":"355_CR18","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/biof.2042","volume":"50","author":"N Savic","year":"2024","unstructured":"Savic N, Markelic M, Stancic A, Velickovic K, Grigorov I, Vucetic M, et al. Sulforaphane prevents diabetes-induced hepatic ferroptosis by activating Nrf2 signaling axis. Biofactors. 2024;50:810\u201327.","journal-title":"Biofactors"},{"key":"355_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s41420-023-01477-z","volume":"9","author":"Y Gong","year":"2023","unstructured":"Gong Y, Liu Z, Zhang Y, Zhang J, Zheng Y, Wu Z. AGER1 deficiency-triggered ferroptosis drives fibrosis progression in nonalcoholic steatohepatitis with type 2 diabetes mellitus. Cell Death Discov. 2023;9:178.","journal-title":"Cell Death Discov"},{"key":"355_CR20","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1084\/jem.145.4.819","volume":"145","author":"M Olsson","year":"1977","unstructured":"Olsson M, Lindahl G, Ruoslahti E. Genetic control of alpha-fetoprotein synthesis in the mouse. J Exp Med. 1977;145:819\u201327.","journal-title":"J Exp Med"},{"key":"355_CR21","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1073\/pnas.0408555102","volume":"102","author":"S Perincheri","year":"2005","unstructured":"Perincheri S, Dingle RW, Peterson ML, Spear BT. Hereditary persistence of alpha-fetoprotein and H19 expression in liver of BALB\/cJ mice is due to a retrovirus insertion in the Zhx2 gene. Proc Natl Acad Sci USA. 2005;102:396\u2013401.","journal-title":"Proc Natl Acad Sci USA"},{"key":"355_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.semcancer.2011.01.001","volume":"21","author":"ML Peterson","year":"2011","unstructured":"Peterson ML, Ma C, Spear BT. Zhx2 and Zbtb20: novel regulators of postnatal alpha-fetoprotein repression and their potential role in gene reactivation during liver cancer. Semin Cancer Biol. 2011;21:21\u20137.","journal-title":"Semin Cancer Biol"},{"key":"355_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.biocel.2014.08.021","volume":"55","author":"F Luan","year":"2014","unstructured":"Luan F, Liu P, Ma H, Yue X, Liu J, Gao L, et al. Reduced nucleic ZHX2 involves in oncogenic activation of glypican 3 in human hepatocellular carcinoma. Int J Biochem Cell Biol. 2014;55:129\u201335.","journal-title":"Int J Biochem Cell Biol"},{"key":"355_CR24","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/s41418-019-0453-z","volume":"27","author":"Z Wu","year":"2020","unstructured":"Wu Z, Ma H, Wang L, Song X, Zhang J, Liu W, et al. Tumor suppressor ZHX2 inhibits NAFLD-HCC progression via blocking LPL-mediated lipid uptake. Cell Death Differ. 2020;27:1693\u2013708.","journal-title":"Cell Death Differ"},{"key":"355_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/hep.32165","volume":"75","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Gao L, Jiang C, Chen J, Qin Z, Zhong F, et al. The transcription factor zinc fingers and homeoboxes 2 alleviates NASH by transcriptional activation of phosphatase and tensin homolog. Hepatology. 2022;75:939\u201354.","journal-title":"Hepatology"},{"key":"355_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05708-0","volume":"14","author":"R Miao","year":"2023","unstructured":"Miao R, Fang X, Zhang Y, Wei J, Zhang Y, Tian J. Iron metabolism and ferroptosis in type 2 diabetes mellitus and complications: mechanisms and therapeutic opportunities. Cell Death Dis. 2023;14:186.","journal-title":"Cell Death Dis"},{"key":"355_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40164-022-00269-y","volume":"11","author":"X Chen","year":"2022","unstructured":"Chen X, Zhou X, Wang X. m(6)A binding protein YTHDF2 in cancer. Exp Hematol Oncol. 2022;11:21.","journal-title":"Exp Hematol Oncol"},{"key":"355_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X, et al. Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res. 2024;43:108.","journal-title":"J Exp Clin Cancer Res"},{"key":"355_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2337\/db16-0806","volume":"66","author":"JS Skyler","year":"2017","unstructured":"Skyler JS, Bakris GL, Bonifacio E, Darsow T, Eckel RH, Groop L, et al. Differentiation of diabetes by pathophysiology, natural history, and prognosis. Diabetes. 2017;66:241\u201355.","journal-title":"Diabetes"},{"key":"355_CR30","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Collaborators GBDD.","year":"2023","unstructured":"Collaborators GBDD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402:203\u201334.","journal-title":"Lancet"},{"key":"355_CR31","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","volume":"64","author":"A Green","year":"2021","unstructured":"Green A, Hede SM, Patterson CC, Wild SH, Imperatore G, Roglic G, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia. 2021;64:2741\u201350.","journal-title":"Diabetologia"},{"key":"355_CR32","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2337\/dc21-1752","volume":"45","author":"JL Harding","year":"2022","unstructured":"Harding JL, Wander PL, Zhang X, Li X, Karuranga S, Chen H, et al. The incidence of adult-onset type 1 diabetes: a systematic review from 32 countries and regions. Diabetes Care. 2022;45:994\u20131006.","journal-title":"Diabetes Care"},{"key":"355_CR33","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202203150","volume":"175","author":"FZ Syed","year":"2022","unstructured":"Syed FZ. Type 1 diabetes mellitus. Ann Intern Med. 2022;175:ITC33\u2013ITC48.","journal-title":"Ann Intern Med"},{"key":"355_CR34","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-023-05964-x","volume":"66","author":"V Lyssenko","year":"2023","unstructured":"Lyssenko V, Vaag A. Genetics of diabetes-associated microvascular complications. Diabetologia. 2023;66:1601\u201313.","journal-title":"Diabetologia"},{"key":"355_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","volume":"30","author":"T Yang","year":"2024","unstructured":"Yang T, Qi F, Guo F, Shao M, Song Y, Ren G, et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med. 2024;30:71.","journal-title":"Mol Med"},{"key":"355_CR36","doi-asserted-by":"publisher","first-page":"e075681","DOI":"10.1136\/bmj-2023-075681","volume":"384","author":"S Subramanian","year":"2024","unstructured":"Subramanian S, Khan F, Hirsch IB. New advances in type 1 diabetes. BMJ. 2024;384:e075681.","journal-title":"BMJ"},{"key":"355_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-024-02145-x","volume":"23","author":"W Bielka","year":"2024","unstructured":"Bielka W, Przezak A, Moleda P, Pius-Sadowska E, Machalinski B. Double diabetes-when type 1 diabetes meets type 2 diabetes: definition, pathogenesis and recognition. Cardiovasc Diabetol. 2024;23:62.","journal-title":"Cardiovasc Diabetol"},{"key":"355_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41574-023-00837-0","volume":"19","author":"D Tatovic","year":"2023","unstructured":"Tatovic D, Narendran P, Dayan CM. A perspective on treating type 1 diabetes mellitus before insulin is needed. Nat Rev Endocrinol. 2023;19:361\u201370.","journal-title":"Nat Rev Endocrinol"},{"key":"355_CR39","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2016.12.011","volume":"101","author":"M Fayfman","year":"2017","unstructured":"Fayfman M, Pasquel FJ, Umpierrez GE. Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Med Clin North Am. 2017;101:587\u2013606.","journal-title":"Med Clin North Am"},{"key":"355_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155658","volume":"146","author":"T Hu","year":"2023","unstructured":"Hu T, Wu Q, Yao Q, Yu J, Jiang K, Wan Y, et al. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy. Metabolism. 2023;146:155658.","journal-title":"Metabolism"},{"key":"355_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14:88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"355_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.12","volume":"2","author":"TY Wong","year":"2016","unstructured":"Wong TY, Cheung CM, Larsen M, Sharma S, Simo R. Diabetic retinopathy. Nat Rev Dis Primers. 2016;2:16012.","journal-title":"Nat Rev Dis Primers"},{"key":"355_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11892-017-0857-4","volume":"17","author":"KK Dhatariya","year":"2017","unstructured":"Dhatariya KK, Vellanki P. Treatment of Diabetic Ketoacidosis (DKA)\/Hyperglycemic Hyperosmolar State (HHS): novel advances in the management of hyperglycemic crises (UK Versus USA). Curr Diab Rep. 2017;17:33.","journal-title":"Curr Diab Rep"},{"key":"355_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41574-021-00621-y","volume":"18","author":"M Fralick","year":"2022","unstructured":"Fralick M, Jenkins AJ, Khunti K, Mbanya JC, Mohan V, Schmidt MI. Global accessibility of therapeutics for diabetes mellitus. Nat Rev Endocrinol. 2022;18:199\u2013204.","journal-title":"Nat Rev Endocrinol"},{"key":"355_CR45","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41581-022-00645-1","volume":"19","author":"P Bjornstad","year":"2023","unstructured":"Bjornstad P, Chao LC, Cree-Green M, Dart AB, King M, Looker HC, et al. Youth-onset type 2 diabetes mellitus: an urgent challenge. Nat Rev Nephrol. 2023;19:168\u201384.","journal-title":"Nat Rev Nephrol"},{"key":"355_CR46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1389557523666230517113936","volume":"24","author":"G Chawla","year":"2024","unstructured":"Chawla G, Pradhan T, Gupta O. An insight into the combat strategies for the treatment of type 2 diabetes mellitus. Mini Rev Med Chem. 2024;24:403\u201330.","journal-title":"Mini Rev Med Chem"},{"key":"355_CR47","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1111\/j.1582-4934.2008.00233.x","volume":"12","author":"H Shen","year":"2008","unstructured":"Shen H, Luan F, Liu H, Gao L, Liang X, Zhang L, et al. ZHX2 is a repressor of alpha-fetoprotein expression in human hepatoma cell lines. J Cell Mol Med. 2008;12:2772\u201380.","journal-title":"J Cell Mol Med"},{"key":"355_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02499-w","volume":"22","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Sun M, Gao L, Liang X, Ma C, Lu J, et al. ZHX2 inhibits thyroid cancer metastasis through transcriptional inhibition of S100A14. Cancer Cell Int. 2022;22:76.","journal-title":"Cancer Cell Int"},{"key":"355_CR49","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1365-2141.2007.06956.x","volume":"141","author":"A Armellini","year":"2008","unstructured":"Armellini A, Sarasquete ME, Garcia-Sanz R, Chillon MC, Balanzategui A, Alcoceba M, et al. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma. Br J Haematol. 2008;141:212\u20135.","journal-title":"Br J Haematol"},{"key":"355_CR50","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aap8411","volume":"361","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018;361:290\u20135.","journal-title":"Science"},{"key":"355_CR51","doi-asserted-by":"publisher","first-page":"e70412","DOI":"10.7554\/eLife.70412","volume":"10","author":"W Fang","year":"2021","unstructured":"Fang W, Liao C, Shi R, Simon JM, Ptacek TS, Zurlo G, et al. ZHX2 promotes HIF1alpha oncogenic signaling in triple-negative breast cancer. Elife. 2021;10:e70412.","journal-title":"Elife"},{"key":"355_CR52","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/bj20030171","volume":"373","author":"H Kawata","year":"2003","unstructured":"Kawata H, Yamada K, Shou Z, Mizutani T, Yazawa T, Yoshino M, et al. Zinc-fingers and homeoboxes (ZHX) 2, a novel member of the ZHX family, functions as a transcriptional repressor. Biochem J. 2003;373:747\u201357.","journal-title":"Biochem J"},{"key":"355_CR53","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1053\/j.gastro.2012.02.049","volume":"142","author":"X Yue","year":"2012","unstructured":"Yue X, Zhang Z, Liang X, Gao L, Zhang X, Zhao D, et al. Zinc fingers and homeoboxes 2 inhibits hepatocellular carcinoma cell proliferation and represses expression of Cyclins A and E. Gastroenterology. 2012;142:1559\u201370.e2.","journal-title":"Gastroenterology"},{"key":"355_CR54","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.4049\/jimmunol.1901246","volume":"204","author":"Z Wang","year":"2020","unstructured":"Wang Z, Kong L, Tan S, Zhang Y, Song X, Wang T, et al. Zhx2 accelerates sepsis by promoting macrophage glycolysis via Pfkfb3. J Immunol. 2020;204:2232\u201341.","journal-title":"J Immunol"},{"key":"355_CR55","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1089\/ars.2023.0291","volume":"40","author":"P Pang","year":"2023","unstructured":"Pang P, Si W, Wu H, Ju J, Liu K, Wang C. et al. YTHDF2 Promotes Cardiac Ferroptosis via Degradation of SLC7A11 in Cardiac Ischemia-Reperfusion Injury. Antioxid Redox Signal. 2023;40:889\u2013905.","journal-title":"Antioxid Redox Signal"},{"key":"355_CR56","doi-asserted-by":"publisher","first-page":"10197","DOI":"10.1111\/jcmm.16957","volume":"25","author":"Z Fan","year":"2021","unstructured":"Fan Z, Yang G, Zhang W, Liu Q, Liu G, Liu P, et al. Hypoxia blocks ferroptosis of hepatocellular carcinoma via suppression of METTL14 triggered YTHDF2-dependent silencing of SLC7A11. J Cell Mol Med. 2021;25:10197\u2013212.","journal-title":"J Cell Mol Med"},{"key":"355_CR57","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41420-023-01746-x","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang G, Mi W, Wang C, Li J, Zhang Y, Liu N, et al. Targeting AKT induced Ferroptosis through FTO\/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer. Cell Death Discov. 2023;9:457.","journal-title":"Cell Death Discov"}],"container-title":["Nutrition & Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00355-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T06:13:18Z","timestamp":1740204798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41387-025-00355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,22]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["355"],"URL":"https:\/\/doi.org\/10.1038\/s41387-025-00355-0","relation":{},"ISSN":["2044-4052"],"issn-type":[{"value":"2044-4052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,22]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All animal care and handling were carried out according to international laws and policies, and all animal experiments were approved by the animal ethics committee of the Southwest Medical University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"6"}}